BT5528

E1266363 UNEXPLORED

BT5528 is an investigational cancer therapy developed by Bicycle Therapeutics that uses bicyclic peptide technology to selectively target and deliver cytotoxic agents to tumor cells.

All labels observed (1)

Label Occurrences
BT5528 canonical 1

How this entity was disambiguated

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.